196 related articles for article (PubMed ID: 27816260)
1. The ABCC2 c.-24C>T polymorphism increases the risk of resistance to antiepileptic drugs: A meta-analysis.
Qian L; Fang S; Yan YL; Zeng SS; Xu ZJ; Gong ZC
J Clin Neurosci; 2017 Mar; 37():6-14. PubMed ID: 27816260
[TBL] [Abstract][Full Text] [Related]
2. ABCC2 polymorphisms and haplotype are associated with drug resistance in Chinese epileptic patients.
Qu J; Zhou BT; Yin JY; Xu XJ; Zhao YC; Lei GH; Tang Q; Zhou HH; Liu ZQ
CNS Neurosci Ther; 2012 Aug; 18(8):647-51. PubMed ID: 22630058
[TBL] [Abstract][Full Text] [Related]
3. Impact of ABCC2 genotype on antiepileptic drug response in Caucasian patients with childhood epilepsy.
Ufer M; von Stülpnagel C; Muhle H; Haenisch S; Remmler C; Majed A; Plischke H; Stephani U; Kluger G; Cascorbi I
Pharmacogenet Genomics; 2011 Oct; 21(10):624-30. PubMed ID: 21799461
[TBL] [Abstract][Full Text] [Related]
4. ABCB1 C3435T polymorphism and the risk of resistance to antiepileptic drugs in epilepsy: a systematic review and meta-analysis.
Haerian BS; Roslan H; Raymond AA; Tan CT; Lim KS; Zulkifli SZ; Mohamed EH; Tan HJ; Mohamed Z
Seizure; 2010 Jul; 19(6):339-46. PubMed ID: 20605481
[TBL] [Abstract][Full Text] [Related]
5. A systematic review and meta-analysis of the role of ABCC2 variants on drug response in patients with epilepsy.
Grover S; Kukreti R
Epilepsia; 2013 May; 54(5):936-45. PubMed ID: 23506516
[TBL] [Abstract][Full Text] [Related]
6. Non-response to antiepileptic pharmacotherapy is associated with the ABCC2 -24C>T polymorphism in young and adult patients with epilepsy.
Ufer M; Mosyagin I; Muhle H; Jacobsen T; Haenisch S; Häsler R; Faltraco F; Remmler C; von Spiczak S; Kroemer HK; Runge U; Boor R; Stephani U; Cascorbi I
Pharmacogenet Genomics; 2009 May; 19(5):353-62. PubMed ID: 19415824
[TBL] [Abstract][Full Text] [Related]
7. Genetic association analysis of transporters identifies ABCC2 loci for seizure control in women with epilepsy on first-line antiepileptic drugs.
Grover S; Gourie-Devi M; Bala K; Sharma S; Kukreti R
Pharmacogenet Genomics; 2012 Jun; 22(6):447-65. PubMed ID: 22565165
[TBL] [Abstract][Full Text] [Related]
8. The effects of ABCC2 G1249A polymorphism on the risk of resistance to antiepileptic drugs: a meta-analysis of the literature.
Chen P; Yan Q; Xu H; Lu A; Zhao P
Genet Test Mol Biomarkers; 2014 Feb; 18(2):106-11. PubMed ID: 24325761
[TBL] [Abstract][Full Text] [Related]
9. Lack of association between ABCC2 gene variants and treatment response in epilepsy.
Hilger E; Reinthaler EM; Stogmann E; Hotzy C; Pataraia E; Baumgartner C; Zimprich A; Zimprich F
Pharmacogenomics; 2012 Jan; 13(2):185-90. PubMed ID: 22256867
[TBL] [Abstract][Full Text] [Related]
10. Impact of ABCC2 1249G>A and -24C>T Polymorphisms on Lacosamide Efficacy and Plasma Concentrations in Uygur Pediatric Patients With Epilepsy in China.
Zhao T; Li HJ; Zhang HL; Feng J; Yu J; Wang TT; Sun Y; Yu LH
Ther Drug Monit; 2023 Feb; 45(1):117-125. PubMed ID: 36253887
[TBL] [Abstract][Full Text] [Related]
11. Relationship between ABCB1 3435TT genotype and antiepileptic drugs resistance in Epilepsy: updated systematic review and meta-analysis.
Chouchi M; Kaabachi W; Klaa H; Tizaoui K; Turki IB; Hila L
BMC Neurol; 2017 Feb; 17(1):32. PubMed ID: 28202008
[TBL] [Abstract][Full Text] [Related]
12. The recessive model of MRP2 G1249A polymorphism decrease the risk of drug-resistant in Asian Epilepsy: a systematic review and meta-analysis.
Wang Y; Tang L; Pan J; Li J; Zhang Q; Chen B
Epilepsy Res; 2015 May; 112():56-63. PubMed ID: 25847339
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between polymorphism in ABCC2 gene and response to antiepileptic drug treatment in Croatian patients with epilepsy.
Sporis D; Bozina N; Basić S; Lovrić M; Babić T; Susak I; Marković I
Coll Antropol; 2013 Mar; 37(1):41-5. PubMed ID: 23697249
[TBL] [Abstract][Full Text] [Related]
14. Association of a synonymous GAT3 polymorphism with antiepileptic drug pharmacoresistance.
Kim DU; Kim MK; Cho YW; Kim YS; Kim WJ; Lee MG; Kim SE; Nam TS; Cho KH; Kim YO; Lee MC
J Hum Genet; 2011 Sep; 56(9):640-6. PubMed ID: 21776001
[TBL] [Abstract][Full Text] [Related]
15. Association between the polymorphisms in the ATP-binding cassette genes ABCB1 and ABCC2 and the risk of drug-resistant epilepsy in a Chinese Han population.
Xue T; Lu ZN
Genet Mol Res; 2016 Nov; 15(4):. PubMed ID: 27886333
[TBL] [Abstract][Full Text] [Related]
16. The roles of variants in human multidrug resistance (MDR1) gene and their haplotypes on antiepileptic drugs response: a meta-analysis of 57 studies.
Li H; Wang B; Chang C; Wu M; Xu Y; Jiang Y
PLoS One; 2015; 10(3):e0122043. PubMed ID: 25816099
[TBL] [Abstract][Full Text] [Related]
17. Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.
Ma CL; Wu XY; Zheng J; Wu ZY; Hong Z; Zhong MK
Pharmacogenomics; 2014 Jul; 15(10):1323-36. PubMed ID: 25155934
[TBL] [Abstract][Full Text] [Related]
18. A comprehensive functional and clinical analysis of ABCC2 and its impact on treatment response to carbamazepine.
Rädisch S; Dickens D; Lang T; Bonnett L; Arlanov R; Johnson MR; Schwab M; Marson AG; Pirmohamed M
Pharmacogenomics J; 2014 Oct; 14(5):481-7. PubMed ID: 24567120
[TBL] [Abstract][Full Text] [Related]
19. ABCC2 haplotype is not associated with drug-resistant epilepsy.
Seo T; Ishitsu T; Oniki K; Abe T; Shuto T; Nakagawa K
J Pharm Pharmacol; 2008 May; 60(5):631-5. PubMed ID: 18416940
[TBL] [Abstract][Full Text] [Related]
20. Linkage disequilibrium between polymorphisms of ABCB1 and ABCC2 to predict the treatment outcome of Malaysians with complex partial seizures on treatment with carbamazepine mono-therapy at the Kuala Lumpur Hospital.
Subenthiran S; Abdullah NR; Joseph JP; Muniandy PK; Mok BT; Kee CC; Ismail Z; Mohamed Z
PLoS One; 2013; 8(5):e64827. PubMed ID: 23717663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
